Philips' Diagnostic X-ray Suite to Incorporate Lunit's AI Software
|
By MedImaging International staff writers Posted on 09 Mar 2021 |

Image: Lunit INSIGHT CXR (Photo courtesy of Lunit)
Philips Healthcare (Amsterdam, the Netherlands) has entered into a collaboration with Lunit (Seoul, Korea) that will make Lunit's AI software accessible to users of Philips' diagnostic X-ray solutions.
The agreement is the latest extension of Philips' AI portfolio in precision diagnosis, which leverages this collaboration to achieve better patient outcomes, improve the experience of patients and staff, and lower the cost of care.
Lunit's AI software, Lunit INSIGHT CXR, is designed to provide accurate and instant analysis of chest X-ray images by mapping the location of the findings and displaying the scored calculation of its actual existence. It accurately detects 10 of the most common findings in a chest X-ray, prioritizes cases with abnormality scores, thereby allows fast triage of normal cases and enables radiologists to focus on reading abnormal cases. The algorithm performs at 97-99% accuracy rate, with its performance validated in major publications such as Radiology, JAMA Network Open, etc.
"For most patients, X-ray is the first diagnostic imaging step on their path to a definitive diagnosis," said Daan van Manen, General Manager for Diagnostic X-ray at Philips. "Radiology departments and their technologists are continually under pressure. They face high patient volumes, and every improvement in workflow can make a big impact. The high performance of Lunit's AI has been validated in major clinical journals to improve accuracy and efficiency in workflow. Our partnership with Lunit to incorporate their diagnostic AI into our X-ray suite combines with a host of smart workflow features in the Philips Radiography Unified User Interface (Eleva), our common platform across our digital radiography systems that enables a smooth and efficient, patient-focused workflow."
"By partnering with Philips, one of the biggest medical device companies globally, our AI will be available to its significant global installed base," said Brandon Suh, CEO of Lunit. "With the start of this partnership, we look forward to further expanding our collaboration to make data-driven medicine the new standard of care. Lunit will continue to build upon its current AI offering, making it better and better with time, and will continue to deliver best-in-class AI."
Related Links:
Philips Healthcare
Lunit
The agreement is the latest extension of Philips' AI portfolio in precision diagnosis, which leverages this collaboration to achieve better patient outcomes, improve the experience of patients and staff, and lower the cost of care.
Lunit's AI software, Lunit INSIGHT CXR, is designed to provide accurate and instant analysis of chest X-ray images by mapping the location of the findings and displaying the scored calculation of its actual existence. It accurately detects 10 of the most common findings in a chest X-ray, prioritizes cases with abnormality scores, thereby allows fast triage of normal cases and enables radiologists to focus on reading abnormal cases. The algorithm performs at 97-99% accuracy rate, with its performance validated in major publications such as Radiology, JAMA Network Open, etc.
"For most patients, X-ray is the first diagnostic imaging step on their path to a definitive diagnosis," said Daan van Manen, General Manager for Diagnostic X-ray at Philips. "Radiology departments and their technologists are continually under pressure. They face high patient volumes, and every improvement in workflow can make a big impact. The high performance of Lunit's AI has been validated in major clinical journals to improve accuracy and efficiency in workflow. Our partnership with Lunit to incorporate their diagnostic AI into our X-ray suite combines with a host of smart workflow features in the Philips Radiography Unified User Interface (Eleva), our common platform across our digital radiography systems that enables a smooth and efficient, patient-focused workflow."
"By partnering with Philips, one of the biggest medical device companies globally, our AI will be available to its significant global installed base," said Brandon Suh, CEO of Lunit. "With the start of this partnership, we look forward to further expanding our collaboration to make data-driven medicine the new standard of care. Lunit will continue to build upon its current AI offering, making it better and better with time, and will continue to deliver best-in-class AI."
Related Links:
Philips Healthcare
Lunit
Latest Industry News News
- Nuclear Medicine Set for Continued Growth Driven by Demand for Precision Diagnostics
- GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
- Patient-Specific 3D-Printed Phantoms Transform CT Imaging
- Siemens and Sectra Collaborate on Enhancing Radiology Workflows
- Bracco Diagnostics and ColoWatch Partner to Expand Availability CRC Screening Tests Using Virtual Colonoscopy
- Mindray Partners with TeleRay to Streamline Ultrasound Delivery
- Philips and Medtronic Partner on Stroke Care
- Siemens and Medtronic Enter into Global Partnership for Advancing Spine Care Imaging Technologies
- RSNA 2024 Technical Exhibits to Showcase Latest Advances in Radiology
- Bracco Collaborates with Arrayus on Microbubble-Assisted Focused Ultrasound Therapy for Pancreatic Cancer
- Innovative Collaboration to Enhance Ischemic Stroke Detection and Elevate Standards in Diagnostic Imaging
- RSNA 2024 Registration Opens
- Microsoft collaborates with Leading Academic Medical Systems to Advance AI in Medical Imaging
- GE HealthCare Acquires Intelligent Ultrasound Group’s Clinical Artificial Intelligence Business
- Bayer and Rad AI Collaborate on Expanding Use of Cutting Edge AI Radiology Operational Solutions
- Polish Med-Tech Company BrainScan to Expand Extensively into Foreign Markets
Channels
Radiography
view channel
Routine Mammograms Could Predict Future Cardiovascular Disease in Women
Mammograms are widely used to screen for breast cancer, but they may also contain overlooked clues about cardiovascular health. Calcium deposits in the arteries of the breast signal stiffening blood vessels,... Read more
AI Detects Early Signs of Aging from Chest X-Rays
Chronological age does not always reflect how fast the body is truly aging, and current biological age tests often rely on DNA-based markers that may miss early organ-level decline. Detecting subtle, age-related... Read moreMRI
view channel
New Material Boosts MRI Image Quality
Magnetic resonance imaging (MRI) is a cornerstone of modern diagnostics, yet certain deep or anatomically complex tissues, including delicate structures of the eye and orbit, remain difficult to visualize clearly.... Read more
AI Model Reads and Diagnoses Brain MRI in Seconds
Brain MRI scans are critical for diagnosing strokes, hemorrhages, and other neurological disorders, but interpreting them can take hours or even days due to growing demand and limited specialist availability.... Read moreMRI Scan Breakthrough to Help Avoid Risky Invasive Tests for Heart Patients
Heart failure patients often require right heart catheterization to assess how severely their heart is struggling to pump blood, a procedure that involves inserting a tube into the heart to measure blood... Read more
MRI Scans Reveal Signature Patterns of Brain Activity to Predict Recovery from TBI
Recovery after traumatic brain injury (TBI) varies widely, with some patients regaining full function while others are left with lasting disabilities. Prognosis is especially difficult to assess in patients... Read moreUltrasound
view channel
Reusable Gel Pad Made from Tamarind Seed Could Transform Ultrasound Examinations
Ultrasound imaging depends on a conductive gel to eliminate air between the probe and the skin so sound waves can pass clearly into the body. While the imaging technology is fast, safe, and noninvasive,... Read more
AI Model Accurately Detects Placenta Accreta in Pregnancy Before Delivery
Placenta accreta spectrum (PAS) is a life-threatening pregnancy complication in which the placenta abnormally attaches to the uterine wall. The condition is a leading cause of maternal mortality and morbidity... Read moreNuclear Medicine
view channel
Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies
Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read more
Cancer “Flashlight” Shows Who Can Benefit from Targeted Treatments
Targeted cancer therapies can be highly effective, but only when a patient’s tumor expresses the specific protein the treatment is designed to attack. Determining this usually requires biopsies or advanced... Read moreGeneral/Advanced Imaging
view channel
AI Tool Predicts Side Effects from Lung Cancer Treatment
Radiation therapy is a central treatment for lung cancer, but even carefully targeted radiation can affect surrounding healthy tissue. Patients may develop side effects such as lung inflammation, coughing,... Read more
AI Tool Offers Prognosis for Patients with Head and Neck Cancer
Oropharyngeal cancer is a form of head and neck cancer that can spread through lymph nodes, significantly affecting survival and treatment decisions. Current therapies often involve combinations of surgery,... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more







